N

Minerva Neurosciences

D
NERV
USD
-0.02
(-0.8439%)
مفتوح الان
60.000
حجم التداول
-2.26
الربح لكل سهم
-
العائد الربحي
-0.534091
P/E
16,434,504.10
حجم السوق
اليوم
-0.8439%
1 اسبوع
-2.083%
1 شهر
-12.963%
6 اشهر
-9.266%
12 اشهر
-55.408%
بداية السنة
-61.157%
كل الوقت
0%

Title:
Minerva Neurosciences

Sector:
Healthcare
Industry:
Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
هل تحتاج مساعدة او لديك استفسار؟